Ten-year Risk of Atherosclerotic Cardiovascular Disease Predicts Long-Term Mortality in Lipid-Lowering Therapy

被引：0
|
作者：
Ma, Zhiyuan
Moran, Lynn N.
Shirani, Jamshid
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cholesterol-lowering drugs; Mortality; Risk Factors; Cardiovascular disease prevention;
D O I：
10.1161/circ.148.suppl_1.11813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11813
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
    Bi, Lei
    Yi, Jiayi
    Wu, Chaoqun
    Hu, Shuang
    Zhang, Xingyi
    Lu, Jiapeng
    Liu, Jiamin
    Zhang, Haibo
    Yang, Yang
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Guo, Yuanlin
    Li, Xi
    Zheng, Xin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [2] Atherosclerotic cardiovascular risk and simulation of lipid-lowering therapy in China
    Bi, L. E. I.
    Yi, J. Y.
    Wu, C. Q.
    Lu, J. P.
    Zhang, H. B.
    Yang, Y. A. N. G.
    Li, X. I.
    Zheng, X. I. N.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2567 - 2567
  • [3] Ten-year risk of cancer mortality according to lipid levels and use of lipid-lowering drugs in the French general population
    Berard, E.
    Bongard, V.
    Amouyel, P.
    Arveiler, D.
    Dallongeville, J.
    Wagner, A.
    Cottel, D.
    Haas, B.
    Ruidavets, J. B.
    Ferrieres, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 148 - 148
  • [4] Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease
    Cannon, Christopher P.
    Khan, Irfan
    Klimchak, Alexa C.
    Reynolds, Matthew R.
    Sanchez, Robert J.
    Sasiela, William J.
    JAMA CARDIOLOGY, 2017, 2 (09) : 959 - 966
  • [5] Lipid-lowering therapy for the prevention of atherosclerotic cardiovascular disease: guidelines and clinical practice
    Lucchi, Tiziano
    Cesari, Matteo
    Vergani, Carlo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (04) : 256 - 263
  • [6] Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease
    Karalis, Dean G.
    CURRENT OPINION IN LIPIDOLOGY, 2023, 34 (06) : 252 - 258
  • [7] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [8] Lipid-lowering therapy and long-term survival in heart transplantation
    Stapleton, DD
    Mehra, MR
    Dumas, D
    Smart, FW
    Milani, RV
    Lavie, CJ
    Ventura, HO
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (06): : 802 - &
  • [9] Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
    Faridi, Kamil F.
    Desai, Nihar R.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 14
  • [10] Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
    Desai, Nihar R.
    Farbaniec, Michael
    Karalis, Dean G.
    CLINICAL CARDIOLOGY, 2023, 46 (01) : 13 - 21
12345